Additional blood parameters that showed abnormal values in a large proportion of individuals in our cohort, such as vitamin D deficiency, LDL levels, cholesterol, C3 levels, or platelet mean value, may provide relevant information for treatment options, an aspect not well understood at present, which requires further monitoring in the future. The gene discussed is C3; the disease is vitamin D deficiency.